Drug:
Reaction: PRURITUS
20250101 - 20251231
No. 901 - 1000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 901 | 25095118 |
CA |
30 | 2 |
Swollen tongue, Dyspnoea, Pruritus, Erythema, Hemiplegic migraine, Throat irritation, Throat tightness, Fatigue, |
||||
EPTINEZUMAB-JJMR, |
||||
| 902 | 25095167 |
US |
||
Pruritus, Acne, Skin irritation, Hypersensitivity, Seborrhoea, |
||||
ADAPALENE, ADAPALENE, |
||||
| 903 | 25095222 |
US |
||
Headache, Skin burning sensation, Erythema, Skin swelling, Skin exfoliation, Gait disturbance, Pain, Pruritus, Sensitive skin, Swelling face, Cushingoid, Oral discomfort, |
||||
| 904 | 25095236 |
US |
||
Hypersensitivity, Acne, Pruritus, Erythema, Drug ineffective, Inappropriate schedule of product administration, Underdose, |
||||
ADAPALENE, |
||||
| 905 | 25095277 |
US |
||
Purulent discharge, Cheilitis, Lip scab, Lip dry, Scab, Dry skin, Pruritus, Skin swelling, Rash, |
||||
BENZOYL PEROXIDE, ADAPALENE, |
||||
| 906 | 25095339 |
US |
68 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 907 | 25095438 |
IT |
15 | 2 |
Pruritus, Ear disorder, |
||||
BENDAMUSTINE HCL, |
||||
| 908 | 25095452 |
US |
63 | 2 |
Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 909 | 25095481 |
US |
56 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 910 | 25095580 |
PA |
46 | 2 |
Death, Metastases to bone, Liver disorder, Blister, Alopecia, Pruritus, Hypersensitivity, |
||||
RIBOCICLIB, RIBOCICLIB, FULVESTRANT, |
||||
| 911 | 25095644 |
US |
61 | 1 |
Flushing, Pruritus, Feeling hot, Muscular weakness, Fall, Rash, Fatigue, |
||||
DALFAMPRIDINE, DIROXIMEL FUMARATE, DUPILUMAB, TERIFLUNOMIDE, INTERFERON BETA-1A, |
||||
| 912 | 25095661 |
US |
2 | |
Pruritus, |
||||
DALFAMPRIDINE, |
||||
| 913 | 25095712 |
US |
38 | 1 |
Dry skin, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 914 | 25095722 |
US |
23 | 2 |
Erythema, Pruritus, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 915 | 25095737 |
US |
||
Burning sensation, Pruritus, Nausea, |
||||
LEVOTHYROXINE, |
||||
| 916 | 25095814 |
2 | ||
Rash, Pruritus, Insomnia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 917 | 25095825 |
US |
47 | 2 |
Dermatitis atopic, Rash erythematous, Skin burning sensation, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 918 | 25095839 |
US |
77 | 1 |
Eyelid margin crusting, Pruritus, Injection site pain, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 919 | 25095898 |
GB |
80 | 2 |
Hot flush, Hypotension, Rash, Pruritus, |
||||
BUPIVACAINE, BUPIVACAINE HYDROCHLORIDE IN DEXTROSE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 920 | 25095938 |
FR |
85 | 2 |
Angina pectoris, Abdominal pain upper, Dry mouth, Pruritus, Constipation, Therapeutic product effect incomplete, |
||||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, |
||||
| 921 | 25095945 |
US |
32 | 2 |
Psoriasis, Pruritus, Erythema, Burning sensation, |
||||
LEVONORGESTREL, |
||||
| 922 | 25096035 |
CN |
38 | 2 |
Skin exfoliation, Pruritus, Rash, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 923 | 25096048 |
US |
29 | 2 |
Inflammation, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 924 | 25096131 |
SI |
66 | 1 |
Oxygen saturation decreased, Hypotension, Pruritus, Erythema, Heart rate increased, |
||||
IOPROMIDE, |
||||
| 925 | 25096151 |
IT |
59 | 2 |
Apnoea, Immunodeficiency, Influenza, Pyrexia, Hypercholesterolaemia, Psoriasis, Skin haemorrhage, Scab, Pruritus, Anxiety, Stress, COVID-19, Pyrexia, Dyspnoea, Diarrhoea, Cough, Fatigue, Nausea, Vomiting, Psychiatric symptom, Nasopharyngitis, Bronchitis, Injection site pain, Wrong technique in device usage process, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 926 | 25096260 |
US |
63 | 2 |
Swelling face, Pruritus, Off label use, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 927 | 25096362 |
US |
67 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 928 | 25096485 |
IR |
42 | 2 |
Coma, Pruritus, |
||||
NATALIZUMAB, |
||||
| 929 | 25096503 |
US |
74 | 1 |
Pruritus, |
||||
| 930 | 25096536 |
US |
4 | 2 |
Dry skin, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 931 | 25096551 |
US |
45 | 2 |
Eczema, Pruritus, Sleep disorder due to a general medical condition, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 932 | 25096568 |
US |
66 | 2 |
Breast cancer recurrent, Myalgia, Vitamin D decreased, Pruritus, Blister, Hot flush, Ear pruritus, Abdominal hernia, Pain in extremity, Swelling, Osteopenia, Acne, Abdominal distension, Rash, COVID-19, Alopecia, Central obesity, Product dose omission issue, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, LETROZOLE, LETROZOLE, LETROZOLE, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, |
||||
| 933 | 25096674 |
CN |
59 | 1 |
Pruritus, Rash erythematous, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 934 | 25096777 |
US |
43 | 2 |
Pruritus, |
||||
EPTINEZUMAB-JJMR, BROMOCRIPTINE MESYLATE, FLUTICASONE PROPIONATE, MUPIROCIN, MUPIROCIN CALCIUM, RIMEGEPANT SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, MONTELUKAST SODIUM, MELATONIN, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 935 | 25097099 |
CA |
1 | |
Gastrointestinal obstruction, Vomiting, Headache, Pruritus, |
||||
UPADACITINIB, PREDNISONE, |
||||
| 936 | 25097103 |
US |
40 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 937 | 25097128 |
US |
69 | 2 |
Bone operation, Pruritus, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 938 | 25097157 |
US |
74 | 2 |
Urticaria, Pruritus, Swelling face, |
||||
BROMFENAC SODIUM, GENTAMICIN SULFATE, DIFLUPREDNATE, ATENOLOL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, LISINOPRIL, MONTELUKAST SODIUM, SIMVASTATIN, PREDNISONE, |
||||
| 939 | 25097238 |
US |
44 | 1 |
Pruritus, Eye pruritus, |
||||
DUPILUMAB, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, MELOXICAM, TIRZEPATIDE, |
||||
| 940 | 25100365 |
36 | 1 | |
Throat irritation, Pruritus, Nasal congestion, Sneezing, Wheezing, Hyperhidrosis, Anxiety, Heart rate decreased, Heart rate increased, Oxygen saturation decreased, Infusion related reaction, |
||||
EPTINEZUMAB-JJMR, |
||||
| 941 | 25086873 |
FR |
||
Poisoning, Diarrhoea, Bone disorder, Bone pain, Fatigue, Constipation, Vomiting, Rash, Product dispensing error, Nausea, Pruritus, Dry mouth, Mucosal inflammation, |
||||
OSIMERTINIB, |
||||
| 942 | 25086970 |
US |
71 | 2 |
Off label use, Deafness, Memory impairment, Pruritus, |
||||
OMALIZUMAB, OMALIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EPINEPHRINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, LISINOPRIL, LEVOTHYROXINE SODIUM, FUROSEMIDE, |
||||
| 943 | 25087111 |
US |
42 | 2 |
Tumour pain, Crying, Pruritus, Cough, Oropharyngeal pain, Fatigue, Productive cough, Illness, Somnolence, Diarrhoea, Hypophagia, Retching, Nausea, Headache, Feeling abnormal, Pain, Influenza like illness, Insomnia, Restless legs syndrome, Vomiting, Pyrexia, Chills, Migraine, Abdominal pain, Product dose omission issue, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, NIROGACESTAT, NIROGACESTAT, PROCHLORPERAZINE, PROCHLORPERAZINE, |
||||
| 944 | 25087120 |
US |
76 | 2 |
Dry skin, Pruritus, |
||||
ADALIMUMAB, ETANERCEPT, |
||||
| 945 | 25087172 |
US |
2 | |
Diarrhoea, Pruritus, |
||||
RIVAROXABAN, |
||||
| 946 | 25087182 |
US |
||
Pruritus, Erythema, Urticaria, Drug hypersensitivity, Off label use, Product prescribing issue, Skin atrophy, Rash, |
||||
ROSUVASTATIN, |
||||
| 947 | 25087219 |
US |
||
Erythema, Pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 948 | 25087246 |
US |
1 | |
Pruritus, |
||||
GLECAPREVIR AND PIBRENTASVIR, |
||||
| 949 | 25087301 |
CA |
43 | 2 |
Exposure during pregnancy, Laryngitis, Live birth, Liver function test increased, Liver injury, Lower limb fracture, Lupus-like syndrome, Lupus vulgaris, Maternal exposure during pregnancy, Memory impairment, Mobility decreased, Infusion related reaction, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Injury, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Prescribed underdose, Prescribed overdose, Product use issue, Intentional product use issue, Product use in unapproved indication, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 950 | 25087308 |
US |
62 | 1 |
Eczema, Blister, Pruritus, |
||||
| 951 | 25087314 |
CA |
50 | 2 |
Anti-cyclic citrullinated peptide antibody positive, Type 2 diabetes mellitus, C-reactive protein abnormal, Ill-defined disorder, Blood cholesterol increased, Rheumatoid arthritis, Dizziness, Lower limb fracture, Product use issue, Therapy non-responder, Musculoskeletal stiffness, Therapeutic product effect decreased, Duodenal ulcer perforation, Liver disorder, Glossodynia, Systemic lupus erythematosus, Nasopharyngitis, Swollen joint count, General physical health deterioration, Sleep disorder due to general medical condition, hypersomnia type, Autoimmune disorder, Bursitis, Abdominal discomfort, Joint range of motion decreased, Folliculitis, Gastrointestinal disorder, Irritable bowel syndrome, Arthralgia, Injury, Gait inability, Liver injury, Peripheral venous disease, Prescribed overdose, Fibromyalgia, Contraindicated product administered, Asthenia, Infection, Hepatic enzyme increased, Sciatica, Asthma, Peripheral swelling, Hypoaesthesia, Arthropathy, Dry mouth, Obesity, Psoriatic arthropathy, Contusion, Drug hypersensitivity, Dyspnoea, Confusional state, Blister, Wound, Rheumatoid factor positive, Maternal exposure during pregnancy, C-reactive protein, Mobility decreased, Musculoskeletal pain, Hypersensitivity, Paraesthesia, Lung disorder, Muscle spasms, Malaise, Helicobacter infection, Infusion related reaction, Sinusitis, Inflammation, Impaired healing, Anxiety, Hip arthroplasty, Pain, Lip dry, Pyrexia, Knee arthroplasty, Joint swelling, Vomiting, Sleep disorder due to general medical condition, insomnia type, Decreased appetite, Wheezing, Abdominal pain upper, Condition aggravated, Osteoarthritis, Tender joint count, Hand deformity, Pruritus, Fatigue, Weight increased, Facet joint syndrome, Pericarditis, Alopecia, Nausea, Discomfort, Stomatitis, Urticaria, Diarrhoea, Night sweats, Rash, Hypertension, Pemphigus, Lower respiratory tract infection, Oedema, Pregnancy, Rheumatic fever, Treatment failure, Drug ineffective, Swelling, Road traffic accident, Deep vein thrombosis postoperative, Synovitis, Chest pain, Muscle injury, Intentional product use issue, Headache, Swollen joint count increased, Drug intolerance, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SECUKINUMAB, SECUKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, MELOXICAM, OXYCODONE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, MAGNESIUM, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LANSOPRAZOLE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, LANSOPRAZOLE, LORAZEPAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, METHYLPREDNISOLONE SODIUM SUCCINATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PIROXICAM, DICLOFENAC SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, VITAMIN C, VITAMIN C, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RAMIPRIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CALCIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYALURONIDASE, CAFFEINE CITRATE, RISEDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CETRIMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MOXIFLOXACIN HYDROCHLORIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE BUTYRATE, LISINOPRIL, LISINOPRIL, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CAFFEINE, SARILUMAB, SARILUMAB, SARILUMAB, LORAZEPAM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LISINOPRIL, |
||||
| 952 | 25087409 |
US |
2 | |
Pruritus, Nodular rash, Hot flush, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 953 | 25087541 |
US |
69 | 1 |
Pruritus, Rash, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 954 | 25087634 |
US |
44 | 1 |
Erythema, Pruritus, |
||||
GUSELKUMAB, |
||||
| 955 | 25087778 |
CA |
64 | 1 |
Ear pruritus, Inappropriate schedule of product administration, Lower respiratory tract infection, Pruritus, Therapeutic response shortened, Tooth infection, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 956 | 25087816 |
US |
68 | 1 |
Abdominal discomfort, Dry skin, Haemorrhage, Discharge, Eye irritation, Skin exfoliation, Dry skin, Balance disorder, Agitation, Sleep disorder, Pruritus, Skin fissures, |
||||
TRALOKINUMAB-LDRM, VALACYCLOVIR HYDROCHLORIDE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 957 | 25087818 |
US |
18 | |
Pruritus, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 958 | 25088446 |
US |
||
Myxoma, Cardiac failure chronic, Dilated cardiomyopathy, Wheezing, Syncope, Pruritus, Dyspnoea, Nausea, Weight decreased, Hypotension, Chest discomfort, Fatigue, Pain, Tachycardia, Vomiting, Vertigo, Urticaria, Asthma, |
||||
| 959 | 25088465 |
PL |
||
Off label use, Hyponatraemia, Orthostatic hypotension, Hypotonia, Blood urea increased, Parkinsonism, Dementia, Sedation, Drug dependence, Motor dysfunction, Constipation, Blood potassium increased, Dysuria, Neuroglycopenia, Blood pressure decreased, Urinary retention, Mobility decreased, Initial insomnia, Blood cholesterol decreased, Gastric polyps, Atrioventricular block first degree, Syncope, Bradykinesia, Hypotonia, Hypotension, Muscle rigidity, Melaena, Fall, Gastrointestinal disorder, Abdominal pain upper, Stupor, Atrial fibrillation, Hypotension, Hypoglycaemia, Hypertension, Hyperkalaemia, Cognitive disorder, Hiatus hernia, Osteoporosis, Multiple drug therapy, Peripheral circulatory failure, General physical health deterioration, Blood creatinine increased, Diabetes mellitus inadequate control, Dizziness, Arthralgia, Insomnia, Depression, Pruritus, Hyperglycaemia, Nausea, |
||||
ALLOPURINOL, ALLOPURINOL, ALPRAZOLAM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DABIGATRAN ETEXILATE, DABIGATRAN ETEXILATE, DENOSUMAB, DONEPEZIL HYDROCHLORIDE, FUROSEMIDE, HYDROCHLOROTHIAZIDE, HYDROXYZINE, HYDROXYZINE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, RAMIPRIL, RAMIPRIL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, SPIRONOLACTONE, TRAMADOL HYDROCHLORIDE, TORSEMIDE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE, VORTIOXETINE, ACARBOSE, AMLODIPINE BESYLATE, DEXTROSE MONOHYDRATE, DEXTROSE, HYDROXYZINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 960 | 25088743 |
US |
||
Limb discomfort, Pain in extremity, Pruritus, Abdominal pain upper, |
||||
AMLODIPINE, |
||||
| 961 | 25088774 |
US |
44 | 2 |
Blood alkaline phosphatase increased, Aspartate aminotransferase increased, Pruritus, |
||||
SELADELPAR LYSINE, |
||||
| 962 | 25088787 |
GB |
46 | 2 |
Liver disorder, Pruritus, |
||||
TERIFLUNOMIDE, |
||||
| 963 | 25088910 |
US |
1 | |
Pruritus, Product use issue, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 964 | 25089001 |
CA |
88 | 1 |
Death, Pruritus, |
||||
TAFAMIDIS, |
||||
| 965 | 25089430 |
US |
||
Pruritus, |
||||
VIBEGRON, |
||||
| 966 | 25089453 |
71 | ||
Memory impairment, Pruritus, Product dose omission issue, Weight increased, |
||||
RUXOLITINIB, |
||||
| 967 | 25089484 |
US |
56 | 2 |
Urticaria, Pruritus, Off label use, |
||||
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, |
||||
| 968 | 25089498 |
US |
2 | |
Pruritus, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 969 | 25089591 |
US |
85 | 2 |
Dermatitis, Skin infection, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 970 | 25089612 |
US |
60 | 2 |
Pain, Dry mouth, Oral pain, Dry skin, Pruritus, Headache, Product dose omission issue, |
||||
FEDRATINIB HYDROCHLORIDE, |
||||
| 971 | 25089618 |
CA |
||
Asthenia, Blood glucose abnormal, Depressed mood, Diabetes mellitus inadequate control, Diabetic ketoacidosis, Medical device site cellulitis, Puncture site swelling, Fatigue, Pruritus, Feeling abnormal, Urticaria, Insomnia, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, INSULIN GLULISINE, |
||||
| 972 | 25089694 |
US |
||
Swelling, Pruritus, |
||||
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, |
||||
| 973 | 25089835 |
CA |
||
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pyrexia, Rheumatoid arthritis, Sinusitis, Sleep disorder, Gastrointestinal disorder, Rash, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Wound, Weight increased, Hepatic enzyme increased, Insomnia, Fatigue, Arthralgia, Pruritus, Hypersensitivity, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, APREPITANT, LEFLUNOMIDE, CETRIMIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, OXYCODONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, |
||||
| 974 | 25089887 |
CN |
53 | |
Myelosuppression, Pruritus, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 975 | 25089934 |
72 | ||
Pruritus, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
| 976 | 25089943 |
US |
79 | 2 |
Plasma cell myeloma, Pruritus, |
||||
| 977 | 25090081 |
US |
||
Pruritus, Throat tightness, Odynophagia, Fall, |
||||
OCRELIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 978 | 25090178 |
US |
1 | |
Pruritus, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 979 | 25090213 |
US |
65 | 2 |
Food poisoning, Lung disorder, Influenza, Cough, Gait disturbance, Asthenia, Anxiety, Myalgia, Muscle fatigue, Appetite disorder, Muscular weakness, Blood bicarbonate decreased, Pyrexia, Brain fog, Abdominal discomfort, Vision blurred, Productive cough, Feeling abnormal, Bone pain, Chest pain, Depression, Hypersomnia, Injury, Rhinorrhoea, Nasal congestion, Pain, Familial periodic paralysis, Pulmonary function test decreased, Panic reaction, Stress, Blood urea decreased, Nightmare, Carbon dioxide increased, Diaphragmatic disorder, Renal disorder, Chromaturia, Dysphagia, Illness, Aphasia, Electrocardiogram T wave abnormal, Blood creatinine increased, Blood calcium abnormal, Hypoaesthesia, Taste disorder, Paralysis, Fall, Unevaluable event, Blood potassium decreased, Syncope, Metabolic acidosis, Malaise, Fatigue, Electrocardiogram QT prolonged, Insomnia, Blood sodium decreased, Heart rate increased, Dry mouth, Nausea, Diarrhoea, Rash, Dyspnoea, Pruritus, COVID-19, Product dose omission in error, |
||||
VENLAFAXINE HYDROCHLORIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, DICHLORPHENAMIDE, |
||||
| 980 | 25090334 |
US |
70 | 1 |
Rash, Pruritus, |
||||
PEMBROLIZUMAB, |
||||
| 981 | 25090348 |
US |
77 | 1 |
Pruritus, Off label use, |
||||
| 982 | 25090353 |
JP |
74 | 1 |
Pemphigoid, Blister, Rash, Pruritus, |
||||
SITAGLIPTIN, |
||||
| 983 | 25090392 |
US |
39 | 1 |
Skin burning sensation, Erythema, Pruritus, |
||||
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, |
||||
| 984 | 25090417 |
US |
78 | 1 |
Eye swelling, Swelling, Pruritus, Rash, |
||||
LATANOPROST, LATANOPROST, |
||||
| 985 | 25090449 |
US |
||
Abdominal rigidity, Pruritus, |
||||
ENCORAFENIB, BINIMETINIB, |
||||
| 986 | 25090581 |
CN |
55 | 2 |
Anaphylactic shock, Amaurosis fugax, Blood pressure decreased, Pruritus, Heart rate decreased, Respiratory rate increased, Depressed mood, |
||||
IOPROMIDE, IOPROMIDE, |
||||
| 987 | 25090792 |
74 | 2 | |
Infusion related reaction, Pruritus, Swelling face, Lip swelling, Rash erythematous, |
||||
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, |
||||
| 988 | 25090793 |
43 | 2 | |
Tachycardia, Throat irritation, Pruritus, |
||||
| 989 | 25090805 |
|||
Fatigue, Myocardial infarction, Splenomegaly, Haematocrit increased, Platelet count increased, Myelofibrosis, Pruritus, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, PEGINTERFERON ALFA-2A, ROPEGINTERFERON ALFA-2B, |
||||
| 990 | 25090821 |
CA |
1 | |
Mental disorder, Pruritus, |
||||
RISANKIZUMAB-RZAA, |
||||
| 991 | 25090926 |
CA |
75 | 2 |
Erythema, Product quality issue, Pruritus, Type IV hypersensitivity reaction, Urticaria, Product use in unapproved indication, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, |
||||
| 992 | 25090993 |
CA |
26 | 2 |
Blood immunoglobulin G decreased, Pregnancy, Illness, Weight increased, Upper respiratory tract infection bacterial, Viral infection, Inappropriate schedule of product administration, Product dispensing error, Oxygen saturation abnormal, Rash maculo-papular, Fatigue, Pruritus, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, IRON, ERGOCALCIFEROL, |
||||
| 993 | 25091010 |
CA |
2 | |
Eczema, Alopecia, Pruritus, Dermatitis, Incorrect dose administered, |
||||
ALLOPURINOL, HYDROCHLOROTHIAZIDE, AMLODIPINE, CYCLOSPORINE, ERGOCALCIFEROL, CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, LATANOPROSTENE BUNOD, FAMOTIDINE, |
||||
| 994 | 25091018 |
CA |
39 | 2 |
Infusion site reaction, Infusion site urticaria, Infusion site pruritus, Dermatitis contact, Incorrect drug administration rate, Inappropriate schedule of product administration, Pruritus, Burning sensation, Infusion site erythema, |
||||
| 995 | 25091019 |
CA |
77 | 2 |
Infusion site erythema, Infusion site discomfort, Arthritis, Infusion related reaction, Eye swelling, Infusion site swelling, Weight increased, Heart rate increased, Thyroid hormones decreased, Injection site erythema, Peripheral swelling, Joint swelling, Swelling face, Pruritus, Burning sensation, Diarrhoea, Dizziness, Blood pressure increased, Erythema, Fatigue, Headache, Product preparation issue, Product use issue, |
||||
BENRALIZUMAB, RABEPRAZOLE, LEVOTHYROXINE SODIUM, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL, IPRATROPIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, |
||||
| 996 | 25091056 |
ES |
89 | 1 |
Pruritus, Erythema, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 997 | 25091080 |
CA |
46 | 2 |
Infusion site erythema, Infusion site pruritus, Dermatitis contact, Product storage error, Infusion site dryness, Feeling abnormal, Influenza, Inappropriate schedule of product administration, Sinusitis, Abdominal discomfort, Blood pressure decreased, Malaise, Pruritus, Fatigue, Vomiting, Lethargy, Erythema, Infusion site induration, Infusion site pain, |
||||
LANSOPRAZOLE, ERGOCALCIFEROL, VITAMIN C, IRON, |
||||
| 998 | 25091190 |
CA |
2 | |
Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, CALCIUM GLUCONATE, DESOGESTREL AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 999 | 25091197 |
BE |
54 | 2 |
Pruritus, Insomnia, Fatigue, Diarrhoea, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, |
||||
| 1000 | 25091205 |
US |
||
Dysgeusia, Palmar erythema, Swelling face, Oral mucosal erythema, Oral pruritus, Pruritus, |
||||
TESAMORELIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28